Dietary aspirin decreases the stage of ovarian cancer in the hen

Gynecologic Oncology

Volumn 112, Issue 1, 2009, Pages 166-170

  Urick, M E ^a   Giles, J R ^a   Johnson, P A ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Aspirin; COX; Cyclooxygenase; Hen; NSAID; Ovarian cancer

Indexed keywords

ACETYLSALICYLIC ACID; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER MODEL; CANCER STAGING; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; ENZYME IMMUNOASSAY; FEMALE; HEN; IMMUNOHISTOCHEMISTRY; NONHUMAN; OVARY; OVARY CANCER; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHICKENS; DIET; DINOPROSTONE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; INCIDENCE; LIVER; NEOPLASM STAGING; OVARIAN NEOPLASMS;

EID: 57649083813     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.09.032     Document Type: Article

References (27)

1. Thun M.J., Namboodiri M.M., and Heath C.W. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med. 325 (1991) 1593-1596
2. Johnson T.W., Anderson K.E., Lazovich D., and Folsom A.R. Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 1586-1591
3. Anderson K.E., Johnson T.W., Lazovich D., and Folsom A.R. Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer. J. Natl. Cancer Inst. 94 (2002) 1168-1171
4. Bardia A., Eggert J.O., Vierkant R.A., Limburg P.J., Anderson K., Wang A.H., et al. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality. J. Natl. Cancer Inst. 99 (2007) 881-889
5. Schildkraut J.M., Moorman P.G., Halabi S., Calingaert B., Marks J.R., and Berchuck A. Analgesic drug use and risk of ovarian cancer. Epidemiology 17 1 (2006) 104-107
6. Harris R.E., Beebe-Donk J., Doss H., and Doss D.B. Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade. Oncol. Rep. 13 (2005) 559-583
7. Sorensen H.T., Friis S., Norgard B., Mellemkjaer L., Blot W.J., McLaughlin J.K., et al. Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br. J. Cancer 88 (2003) 1687-1692
8. Akhmedkhanov A., Toniolo P., Zeleniuch-Jacquotte A., Kato I., Koenig K.L., and Shore R.E. Aspirin and epithelial ovarian cancer. Prev. Med. 33 (2001) 682-687
9. Wernli K.J., Newcomb P.A., Hampton J.M., Trentham-Dietz A., and Egan K.M. Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity. Br. J. Cancer 98 (2008) 1781-1783
10. Andrews P., Zhao X., Allen J., Li F., and Chang M. A comparison of the effectiveness of selected non-steroidal anti-inflammatory drugs and their derivatives against cancer cells in vitro. Cancer Chemother. Pharmacol. 61 2 (2008) 203-214
11. 1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398 but not by COX-2-specific RNA interference. Oncogene 22 (2003) 8653-8661
12. Rodriguez-Burford C., Barnes M.N., Oelschlager D.K., Myers R.B., Talley L.I., Partridge E.E., et al. Effects of nonsteroidal anti-inflammatory agents (NSAIDs) on ovarian carcinoma cell lines: preclinical evaluation of NSAIDs as chemopreventative agents. Clin. Cancer Res. 8 (2002) 202-209
13. Drake J.G., and Becker J.L. Aspirin-induced inhibition of ovarian tumor cell growth. Obstet. Gynecol. 100 4 (2002) 677-682
14. Wang H.J., Peng Z.L., Liu X.O., Yang K.X., Lou J.Y., and Lou F.M. The growth inhibitory effect of non-steroid anti-inflammatory drugs on ovarian cancer. Sichuan Da Xue Xue Bao Yi Xue Ban 38 3 (2007) 428-432
15. Xin B., Yooyama Y., Shigeto T., Futagami M., and Mizunuma H. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome prolferator-activated receptor gamma ligand, on the growth of human ovarian cancer. Cancer 110 4 (2007) 791-800
16. Vanderhyden B.C., Shaw T.J., and Ethier J.F. Animal models of ovarian cancer. Reprod. Biol. Endo. 1 (2003) 67
17. Fredrickson T.N. Ovarian tumors of the hen. Environ. Health Perspect. 73 (1987) 35-51
18. Urick M.E., Giles J.R., and Johnson P.A. VEGF expression and the effect of NSAIDs on ascites cell proliferation in the hen model of ovarian cancer. Gynecol Oncol 110 3 (2008) 418-424
19. Barua A., Abramowicz J.S., Bahr J.M., Bitterman P., Dirks A., Holub K.A., et al. Detection of ovarian tumors in chicken by sonography; A step toward early diagnosis in humans?. J. Ultrasound Med. 26 (2007) 909-919
20. Balog J.M., and Hester P.Y. The effect of dietary acetylsalicyclic acid on eggshell quality. Poultry Sci. 70 (1991) 624-630
21. McDaniel C.D., Balog J.M., Freed M., Elkin R.G., Wellenreiter R.H., and Hester P.Y. Response of layer breeders to dietary acetylsalicyclic acid. 1. Effects on hen performance and eggshell quality. Poultry Sci. 72 (1993) 1084-1092
22. Urick M.E., and Johnson P.A. Cyclooxygenase 1 and 2 mRNA and protein expression in the Gallus domesticus model of ovarian cancer. Gynecol. Oncol. 103 (2006) 673-678
23. Kushlinskii N.E., Podistov Y.I., Laktionov K.P., Karseladze A.I., Babkina I.V., and Kerimova G.I. Prostaglandins E in primary tumor, metastases, and ascitic fluid of patients with ovarian cancer. Bull. Eksp. Biol. Med. 123 (1997) 83-86
24. Heinonen P.K., and Metsa-Ketela T. Prostaglandin and thromboxane production in ovarian cancer tissue. Gynecol. Obstet. Invest. 18 5 (1984) 225-229
25. Johnson P.A., and Giles J.R. Use of genetic strains of chickens in studies of ovarian cancer. Poultry Sci. 85 (2006) 246-250
26. Papasolomontos P.A., and Mayor O.Y. Pathological findings in condemned chickens: a survey of 1000 carcasses. Vet. Rec. 85 (1969) 459-464
27. Wight P.A.L. Neoplastic sequelae of gonadal maldevelopment in a flock of domestic fowls. Avian Dis. 9 (1965) 327-335